Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain
BioImpacts · 13.09.2018 · 9 (1) · 15-23
DOI: 10.15171/bi.2019.03 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioImpacts, online erschienen am 13.09.2018. Verfasst von Azam Safary und 3 weiteren Autor:innen. Beteiligte Einrichtung: Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The bacterial enzyme has gained more attention in therapeutic application because of the higher substrate specificity and longer half-life. L-asparaginase is an important enzyme with known antineoplastic effect against acute lymphoblastic leukemia (ALL).
Methods
Novel L-asparaginase genes were identified from a locally isolated halo-thermotolerant Bacillus strain and the recombinant enzymes were overexpressed in modified E. coli strains, OrigamiTM B and BL21. In addition, the biochemical properties of the purified enzymes were characterized, and the enzyme activity was evaluated at different temperatures, pH, and substrate concentrations.
Results
The concentration of pure soluble enzyme obtained from Origami strain was ~30 mg/L of bacterial culture, which indicates the significant improvement compared to L-asparaginase produced by E. coli BL21 strain. The catalytic activity assay on the identified L-asparaginases (ansA1 and ansA3 genes) from Bacillus sp. SL-1 demonstrated that only ansA1 gene codes an active and stable homologue (ASPase A1) with high substrate affinity toward L-asparagine. The Kcat and Km values for the purified ASPase A1 enzyme were 23.96s-1 and 10.66 µM, respectively. In addition, the recombinant ASPase A1 enzyme from Bacillus sp. SL-1 possessed higher specificity to L-asparagine than L-glutamine. The ASPase A1 enzyme was highly thermostable and resistant to the wide range of pH 4.5–10.
Conclusion
The biochemical properties of the novel ASPase A1 derived from Bacillus sp. SL-l indicated a great potential for the identified enzyme in pharmaceutical and industrial applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran.
- Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
- Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
- Faculty of Pharmacy, Near East University, POBOX:99138, Nicosia, North Cyprus, Mersin 10, Turkey.
ORCID-Profile: Azam Safary
Zitieren
APA
Safary, A., Moniri, R., Hamzeh-Mivehroud, M., & Dastmalchi, S. (2018). Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain. BioImpacts, 9(1), 15-23. https://doi.org/10.15171/bi.2019.03
Vancouver
Safary A, Moniri R, Hamzeh-Mivehroud M, Dastmalchi S. Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain. BioImpacts. 2018;9(1):15-23. doi:10.15171/bi.2019.03
BibTeX
@article{Safary2018,
author = {Safary, Azam and Moniri, Rezvan and Hamzeh-Mivehroud, Maryam and Dastmalchi, Siavoush},
title = {Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain},
journal = {BioImpacts},
year = {2018},
volume = {9},
number = {1},
pages = {15--23},
doi = {10.15171/bi.2019.03}
}
EUVIMED